Gaby P. Smits

Bilthoven, UT, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 66 publications

Trends in Hepatitis B, Hepatitis C, and HIV Seroprevalence in the Netherlands: Insights From Two Decades of Nationwide PIENTER Serosurveys.

Trends in Hepatitis B, Hepatitis C, and HIV Seroprevalence in the Netherlands: Insights From Two Decades of Nationwide PIENTER Serosurveys.

Journal: Journal of viral hepatitis

Published: February 10, 2026

Trends and patterns of varicella zoster virus infection in Kilifi: A population-based serosurvey.

Trends and patterns of varicella zoster virus infection in Kilifi: A population-based serosurvey.

Journal: PLOS global public health

Published: February 05, 2026

Optimising DTwP-containing vaccine infant immunisation schedules in Uganda and Nepal (OptImms): two open-label, non-inferiority, randomised controlled trials.

Optimising DTwP-containing vaccine infant immunisation schedules in Uganda and Nepal (OptImms): two open-label, non-inferiority, randomised controlled trials.

Journal: The Lancet. Infectious diseases

Published: November 11, 2025

Seroprevalence of antibodies against diphtheria, tetanus, and pertussis over a 12-year period in children in Kilifi, Kenya (2009-2021).

Seroprevalence of antibodies against diphtheria, tetanus, and pertussis over a 12-year period in children in Kilifi, Kenya (2009-2021).

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Published: October 08, 2025

Antibody waning and Bordetella pertussis resurgence after the COVID-19 pandemic in the Netherlands.

Antibody waning and Bordetella pertussis resurgence after the COVID-19 pandemic in the Netherlands.

Journal: Nature communications

Published: August 01, 2025

Antibody concentration and function following SARS-CoV-2 vaccination decrease with age in adults and children with Down syndrome.

Antibody concentration and function following SARS-CoV-2 vaccination decrease with age in adults and children with Down syndrome.

Journal: Vaccine

Published: July 05, 2025

Modelling the relative contribution of infection, routine vaccination and supplementary immunisation activities to measles seroconversion in Kenyan Children.

Modelling the relative contribution of infection, routine vaccination and supplementary immunisation activities to measles seroconversion in Kenyan Children.

Journal: PLoS computational biology

Published: February 20, 2025

Seroprevalence of Immunoglobulin G against measles and rubella over a 12-year period (2009-2021) in Kilifi, Kenya and the impact of the Measles-Rubella (MR) vaccine campaign of 2016.

Seroprevalence of Immunoglobulin G against measles and rubella over a 12-year period (2009-2021) in Kilifi, Kenya and the impact of the Measles-Rubella (MR) vaccine campaign of 2016.

Journal: Vaccine

Published: February 11, 2025

T-cell and antibody responses in immunocompromised patients with hematologic malignancies indicate strong potential of SARS-CoV-2 mRNA vaccines.

T-cell and antibody responses in immunocompromised patients with hematologic malignancies indicate strong potential of SARS-CoV-2 mRNA vaccines.

Journal: Haematologica

Published: December 06, 2024

High SARS-CoV-2 antibody levels after three consecutive BNT162b2 booster vaccine doses in nursing home residents.

High SARS-CoV-2 antibody levels after three consecutive BNT162b2 booster vaccine doses in nursing home residents.

Journal: Immunity & ageing : I & A

Published: November 15, 2024

Long-term Dynamics of Measles Virus-Specific Neutralizing Antibodies in Children Vaccinated Before 12 Months of Age.

Long-term Dynamics of Measles Virus-Specific Neutralizing Antibodies in Children Vaccinated Before 12 Months of Age.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: September 05, 2024

Determinants of Systemic SARS-CoV-2-Specific Antibody Responses to Infection and to Vaccination: A Secondary Analysis of Randomised Controlled Trial Data.

Determinants of Systemic SARS-CoV-2-Specific Antibody Responses to Infection and to Vaccination: A Secondary Analysis of Randomised Controlled Trial Data.

Journal: Vaccines

Published: May 17, 2024

Showing 1-12 of 66

Last Updated: 09/26/2026